Medical breakthrough or biological surveillance? In this November 14, 2017 National Post article (2.5 minute read) written by Caroline Chen, “Not taking your medication? These new digital pills will allow doctors to keep track of your adherence”, we learn of a new version of Otsuka Pharmaceutical’s Abilify drug which has a built-in sensor to allow doctors to monitor whether or not their patients are complying with their prescription. Abilify is used to treat depression, bipolar disorder and schizophrenia.